Biotechs Pressured Following Clinton Tweet (IBB)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/11/2026
- Wall St set to gain on tech rebound, Middle East in focus
- SpaceX prices historic IPO at $135/share in largest ever new listing
- Oil drops as Trump cancels planned strikes against Iran
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- Needham Starts Hyliion Holdings (HYLN) at Buy
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Alibaba falls on China AI capex report; Citi says selloff is premature
Hillary Clinton Tweet Doesn't Change Bullish View on Valeant Pharmaceuticals (VRX), BMO Capital Says
September 21, 2015 1:57 PM EDTBMO Capital analyst Alex Arfaei weighed in on Valeant Pharmaceuticals (NYSE: VRX) which is down 6% in response to a Tweet from Hillary Clinton referring to this article in the... More
UPDATE: Biotech Bounces Off Lows (IBB)
September 21, 2015 1:19 PM EDT(Updated - September 21, 2015 1:29 PM EDT)
Biotech stocks bounced off lows Monday afternoon, paring declines that were largely driven by fears of increased government regulation of drug pricing. The source of concern was a tweet by presidential candidate Hillary Clinton... More
Cowen Remains Bullish on Gilead Sciences (GILD) Following Data Release
September 21, 2015 1:13 PM EDTCowen reiterated an Outperform rating and $125.00 price target on Gilead Sciences (NASDAQ: GILD) following the release top-line data from the Ph. III ASTRAL trials of SOF+VEL.
Analyst Phil Nadeau commented, "GILD released top-line data from the Ph. III ASTRAL trials of... More
